Pegylated liposomal doxorubicin in combination with...

Details Pegylated liposomal doxorubicin in combination with... Pegylated liposomal doxorubicin in combination with...

A - Human Necessities

61

K

A61K 31/704 (2006.01) A61K 9/127 (2006.01) A61K 31/4995 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2582452

A method of treating the human body for cancer comprises administering an effective therapeutic amount of a Pegylated Liposomal form of the anthracycline Doxorubicin ("PLD"), in combination with an effective therapeutic amount of ET-743.

L'invention concerne une méthode de traitement du corps humain dirigée contre le cancer. Cette méthode consiste à administrer une quantité thérapeutique efficace d'une forme liposomale pégylée de l'anthracycline doxorubicine (PLD), combinée à une quantité thérapeutique efficace de ET-743

Affiliated with

Also associated with

Rating

Pegylated liposomal doxorubicin in combination with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pegylated liposomal doxorubicin in combination with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pegylated liposomal doxorubicin in combination with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1378216